Addition of manual daytime exchanges to automated peritoneal dialysis (APD) regimens optimizes solute clearance, but reduces quality of life and might increase the risk of peritonitis. Clinically ...

The US Food and Drug Administration (FDA) has cleared Baxter International's AMIA automated home peritoneal dialysis (APD) system with remote connectivity over the Internet, using the company's ...

Conducted over 5 years, from 2008 to 2013, this RCT tried to determine the optimal time for peritoneal dialysis (PD) after catheter insertion in patients with stage 5 chronic kidney disease. The ideal ...

Kidney disease affects millions globally, often reducing quality of life and daily functioning. In the United States, about 14% of adults have chronic kidney disease (CKD), according to the National ...

First patients have been enrolled in the clinical trial for next generation dialysis technology Innovative system designed to improve home dialysis experience and simplify therapy management New ...

For most people, hemodialysis and peritoneal dialysis are equally effective treatments for end stage renal disease. Factors such as your health, preferences, and the costs may influence your final ...

Baxter has received clearance from the FDA for the latest version of its automated peritoneal dialysis system designed for home use, combining it with a digital platform that aims to help patients ...

Please provide your email address to receive an email when new articles are posted on . In the United States, the annual rate of growth in incident patients with end-stage kidney disease has slowed.

Kidney disease impacts millions globally. Two main treatments, hemodialysis and peritoneal dialysis, offer life-saving solutions. Hemodialysis uses a machine to filter blood, while peritoneal dialysis ...